![Phase 2 to phase 3 clinical trial transitions: Reasons for success and failure in immunologic diseases - Journal of Allergy and Clinical Immunology Phase 2 to phase 3 clinical trial transitions: Reasons for success and failure in immunologic diseases - Journal of Allergy and Clinical Immunology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/74b6b515-2def-41cc-99eb-58a2b72fa5cc/gr1_lrg.jpg)
Phase 2 to phase 3 clinical trial transitions: Reasons for success and failure in immunologic diseases - Journal of Allergy and Clinical Immunology
![Clinical Trial Alert: Phase 3 Study of Rozanolixizumab in Individuals With Generalized Myasthenia Gravis - Muscular Dystrophy Association Clinical Trial Alert: Phase 3 Study of Rozanolixizumab in Individuals With Generalized Myasthenia Gravis - Muscular Dystrophy Association](https://strongly.mda.org/assets/uploads/2021/03/2021-Clinical-Trial-Alert-Facebook-Post-1024x536.jpg)
Clinical Trial Alert: Phase 3 Study of Rozanolixizumab in Individuals With Generalized Myasthenia Gravis - Muscular Dystrophy Association
![Phase 3 clinical trial poster - Warning: TT: undefined function: 32 Warning: TT: undefined function: - StuDocu Phase 3 clinical trial poster - Warning: TT: undefined function: 32 Warning: TT: undefined function: - StuDocu](https://d20ohkaloyme4g.cloudfront.net/img/document_thumbnails/66ff76c14b861a4e2d68e67b90f72e98/thumb_1200_929.png)